-
Enveric Biosciences Advances Testing Of Its Non-Hallucinogenic Psychedelic
Tuesday, October 15, 2024 - 11:27am | 359Read More...Enveric Biosciences (NASDAQ:ENVB), a biotechnology company specializing in neuroplastogenic small-molecule therapeutics, revealed positive data from preclinical safety and pharmacology studies of its lead drug candidate, EB-003. The Massachusetts-based company announced that the results show the...
-
New Patented Psychedelic Drug Brings Hope For Brain Disorder Therapies
Thursday, July 11, 2024 - 2:45pm | 227Read More...Enveric Biosciences (NASDAQ:ENVB), a biotechnology company specializing in neuroplastogenic therapeutics, has been granted a U.S. patent for its drug candidate EB-002. The license, No. 11,945,778, issued by the United States Patent and Trademark Office, includes broad claims for treating brain...
-
Bringing Mental Health Pharmacology into the 21st Century: How the Marriage of Enveric Biosciences and MagicMed Industries Could Revolutionize the Way We Treat Mental Health
Tuesday, October 5, 2021 - 9:07am | 822Read More...The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Photo by Christina Victoria Craft on Unsplash The world is finally waking up to the importance of mental health. It is becoming more...
